Ramona Tanabe is executive vice president and counsel at the Workers Compensation Research Institute in Cambridge, MA. She has been with the company since 1996. Tanabe oversees the data collection and analysis efforts for numerous research projects, including the CompScope Multistate Benchmarks, which measure the performance of a growing number of state workers’ compensation systems.
A new report from the Workers Compensation Research Institute (WCRI) found evidence of frequent physician dispensing of new drug strengths and a new formulation at much higher prices. This phenomenon was observed in several states that recently instituted reforms aimed at reducing the prices for physician-dispensed prescriptions. Skirting the goals of those reforms, dispensing increased for new […]
A new study―Do Higher Fee Schedules Increase the Number of Workers’ Compensation Cases?―from the Workers Compensation Research Institute (WCRI) explores to what extent workers’ compensation reimbursement rates influence the decision by the medical provider on whether to classify an injury as work-related. According to previously published WCRI research, in many states, workers’ compensation pays higher […]
Hundreds of millions of dollars of claims could shift from group health to workers’ compensation as accountable care organizations (ACO) expand under the Affordable Care Act (ACA), according to our new study: Will the Affordable Care Act Shift Claims to Workers’ Compensation Payors? Although pundits have written about “cost shifting” to workers’ compensation, a significant […]
After 18 states enacted reforms to limit the prices paid to doctors for prescriptions they write and dispense, a new study from the Workers Compensation Research Institute (WCRI) finds that physician-dispensers in Illinois and California discovered a new way to continue charging and to get paid two to three times the price of a drug […]
A new study from the Workers Compensation Research Institute (WCRI) showed that Georgia’s changes to the reimbursement rules for physician-dispensed drugs reduced the average price per pill paid by 25% to 40% for most of the drugs commonly dispensed by physicians. However, the post-reform prices paid for physician-dispensed drugs were still 20% to 40% higher […]
Policymakers in many states increasingly enact medical fee schedules in the quest to limit the growth of hospital costs. They often seek a reference point or benchmark to which they can tie reimbursement rates. Usually, that benchmark is either Medicare rates in the state or some measure of historic charges by the hospitals. Medicare rates […]